How big is the Autoimmune Disease Diagnostics Market?

The Autoimmune Disease Diagnostics Market size is expected to reach USD 5.21 billion in 2024 and grow at a CAGR of 5.60% to reach USD 6.84 billion by 2029. Read More

What is the current Autoimmune Disease Diagnostics Market size?

In 2024, the Autoimmune Disease Diagnostics Market size is expected to reach USD 5.21 billion. Read More

Who are the key players in Autoimmune Disease Diagnostics Market?

Abbott Laboratories, Biomérieux, Trinity Biotech, Bio-rad Laboratories and Thermo Fisher Scientific are the major companies operating in the Autoimmune Disease Diagnostics Market. Read More

Which is the fastest growing region in Autoimmune Disease Diagnostics Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Autoimmune Disease Diagnostics Market?

In 2024, the North America accounts for the largest market share in Autoimmune Disease Diagnostics Market. Read More

What years does this Autoimmune Disease Diagnostics Market cover, and what was the market size in 2023?

In 2023, the Autoimmune Disease Diagnostics Market size was estimated at USD 4.93 billion. The report covers the Autoimmune Disease Diagnostics Market historical market size for years: . The report also forecasts the Autoimmune Disease Diagnostics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Autoimmune Disease Diagnostics Market Share

Statistics for the 2023 & 2024 Autoimmune Disease Diagnostics market share, created by Mordor Intelligence™ Industry Reports. Autoimmune Disease Diagnostics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Autoimmune Disease Diagnostics Industry

The autoimmune disease diagnostics Market is moderately competitive. The market comprises significant market players, and these players are focusing on R&D activities and effective growth strategies. Recently, a few diagnostic companies entered into strategic partnerships with hospitals. This trend is expected to continue over the next few years to meet the high volume of patient needs across different regions. Some of the companies currently dominating the market are Abbott Laboratories, Biomérieux, Trinity Biotech, Bio-rad Laboratories, and Thermo Fisher Scientific, among others.